PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PIRITREXIM ADMINISTERED ORALLY ON A 5-DAY SCHEDULE

被引：0
|
作者：
ADAMSON, PC
BALIS, FM
MISER, J
WELLS, RJ
BLEYER, WA
WILLIAMS, TE
GILLESPIE, A
PENTA, JS
CLENDENINN, NJ
POPLACK, DG
机构：
[1] MAYO CLIN,ROCHESTER,MN 55902
[2] CHILDRENS HOSP MED CTR,CINCINNATI,OH 45229
[3] CHILDRENS HOSP,SEATTLE,WA 98105
[4] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[5] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709
来源：
CANCER RESEARCH | 1990年 / 50卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4464 / 4467
页数：4
相关论文
共 50 条
  • [1] PHASE-I TRIAL OF TAXOTERE - 5-DAY SCHEDULE
    PAZDUR, R
    NEWMAN, RA
    NEWMAN, BM
    FUENTES, A
    BENVENUTO, J
    BREADY, B
    MOORE, D
    JAIYESIMI, I
    VREELAND, F
    BAYSSAS, MMG
    RABER, MN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) : 1781 - 1788
  • [2] CHLOROZOTOCIN - PHASE-I TRIAL OF 5-DAY SCHEDULE
    ANDERSON, T
    FISHER, R
    BARLOCK, A
    YOUNG, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 356 - 356
  • [3] PHASE-I CLINICAL-TRIAL OF CARBOPLATIN (CBDCA) ADMINISTERED AT A 5-DAY SCHEDULE
    NICAISE, C
    ROZENCWEIG, M
    BEER, M
    PICCART, M
    CRESPEIGNE, N
    APARICIO, LA
    VANRIJMENANT, M
    LENAZ, L
    KENIS, Y
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 164 - 164
  • [4] PEDIATRIC PHASE-I TRIAL, PHARMACOKINETIC STUDY, AND LIMITED SAMPLING STRATEGY FOR PIRITREXIM ADMINISTERED ON A LOW-DOSE, INTERMITTENT SCHEDULE
    ADAMSON, PC
    BALIS, FM
    MISER, J
    ARNDT, C
    WELLS, RJ
    GILLESPIE, A
    ARONSON, L
    PENTA, JS
    CLENDENINN, NJ
    POPLACK, DG
    [J]. CANCER RESEARCH, 1992, 52 (03) : 521 - 524
  • [5] PHASE-I CLINICAL-STUDY OF DIHYDROXYANTHRACENEDIONE ADMINISTERED ON A 5-DAY IV SCHEDULE
    VALDIVIESO, M
    BEDIKIAN, AY
    BURGESS, MA
    SAVARAJ, N
    JEFFERS, WB
    BODEY, GP
    [J]. CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 841 - 844
  • [6] PHASE-I TRIAL OF PCNU ADMINISTERED BY 5-DAY COURSES
    EARHART, RH
    KOELLER, JM
    DAVIS, HL
    [J]. CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 835 - 840
  • [7] A PHASE-I TRIAL OF PCNU (NSC 95466) ON A 5-DAY SCHEDULE
    EARHART, RH
    KOELLER, JM
    DAVIS, HL
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 356 - 356
  • [8] PHASE-I STUDY OF A 5-DAY SCHEDULE OF MITOXANTRONE (DIHYDROXYANTHRACENEDIONE)
    WYNERT, WR
    HARVEY, HA
    LIPTON, A
    SCHWEITZER, J
    WHITE, DS
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1303 - 1306
  • [9] PHASE-I TRIAL OF HOMOHARRINGTONINE ADMINISTERED AS A 5-DAY CONTINUOUS INFUSION
    COONLEY, CJ
    WARRELL, RP
    YOUNG, CW
    [J]. CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 693 - 696
  • [10] PHASE-I STUDY OF TRIGLYCIDYLURAZOL GIVEN ON A 5-DAY IV SCHEDULE
    NICAISE, C
    ROZENCWEIG, M
    CRESPEIGNE, N
    DODION, P
    GERARD, B
    LAMBERT, M
    DECOSTER, G
    KENIS, Y
    [J]. CANCER TREATMENT REPORTS, 1986, 70 (05): : 599 - 603
12345